Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone? — KYLE Matthew KAMPMAN (UNIVERSITY
Extended-release naltrexone (XR-NTX) reduces overdose risk and is filling a niche for opioid addicted patients that do not want agonist maintenance or cannot access it. However transitioning to naltre
| Project title | Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone? |
|---|---|
| Project number | 5UH3DA049694-03 |
| PI name | KYLE Matthew KAMPMAN |
| Institution | UNIVERSITY OF PENNSYLVANIA |
| Funding mechanism | UH3 |
| Agency | NIDA |
| Award amount | $2.71M |
| Fiscal year | 2024 |
| Project start | 2019-09-30T00:00:00 |
| Project end | 2026-08-31T00:00:00 |
| Abstract | Extended-release naltrexone (XR-NTX) reduces overdose risk and is filling a niche for opioid addicted patients that do not want agonist maintenance or cannot access it. However transitioning to naltre |
| Key terms | <21+ years old><3-isobutyl GABA><4-Aminobutanoic Acid><4-Aminobutyric Acid><4-amino-butanoic acid><A |
$799/mo
Try GrantRadar →